Critical care management of systemic mastocytosis: when every wasp is a killer bee
Tóm tắt
Since the critical care physician will most likely be involved in a life-threatening expression of systemic mastocytosis, recognition of this disease is of utmost importance in the critical care management of these patients. Mastocytosis is a severely under-recognized disease because it typically occurs secondary to another condition and thus may occur more frequently than assumed. In this article, we will review the current knowledge on the treatment of mastocytosis crises with an emphasis on critical care management. Mastocytosis is characterized by the clonal proliferation and accumulation of mast cells in different tissues. Mast cell mediators contain a wide range of biologically active substances that may lead to itching and hives but may ultimately lead to anaphylactic shock caused by the release of histamine and other mediators from mast cells. The mainstay of therapy is the avoidance of potential triggers of mast cell degranulation and, if unsuccessful, blocking the cascade of mast cell mediators. The critical care physician should be well aware of the special precautions which should be kept in mind throughout the management of a mastocytosis crisis to avoid massive mast cell degranulation. Histamine-releasing drugs and certain physical triggers like temperature change should be avoided.
Tài liệu tham khảo
Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157:215–25.
Andersen CL, Kristensen TK, Severinsen MT, Møller MB, Vestergaard H, Bergmann OJ, et al. Systemic mastocytosis – a systematic review. Dan Med J. 2012;59:A439.
Müller UR, Haeberli G. The problem of anaphylaxis and mastocytosis. Curr Allergy Asthma Rep. 2009;9:64–70.
Reiter N, Reiter M, Altrichter S, Becker S, Kristensen T, Broesby-Olsen S, et al. Anaphylaxis caused by mosquito allergy in systemic mastocytosis. Lancet. 2013;382:1380.
Geerlings SE, Canning-v Dijk MR. A patient resuscitated after an insect sting. A clinical pathological conference. Neth J Med. 2001;58:45–51.
Kors JW, van Doormaal JJ, de Monchy JG. Anaphylactic shock following Hymenoptera sting as a presenting symptom of systemic mastocytosis. J Intern Med. 1993;233:255–8.
Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia. 1998;53:804–9.
Yunaev M, Hughes TM, Abdul-Razak M. Systemic mastocytosis and surgery a potential disaster. ANZ J Surg. 2010;80:860–1.
Brockow K, Bonadonna P. Drug allergy in mast cell disease. Curr Opin Allergy Clin Immunol. 2012;12:354–60.
Konrad FM, Schroeder TH. Anaesthesia in patients with mastocytosis. Acta Anaesthesiol Scand. 2009;53:270–1.
Konrad FM, Unertl KE, Schroeder TH. Provocation of mastocytosis in anaesthesia. Anaesthesist. 2009;58:1239–43.
van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, et al. Prevalence of indolent systemic mastocytosis in a Dutch region. J Allergy Clin Immunol. 2013;131:1429–30.
van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, et al. Higher mast cell load decreases the risk of Hymenoptera venom induced anaphylaxis in patients with mastocytosis. J Allergy Clin Immunol. 2013;132:132.
Bonadonna P, Zanotti R, Pagani M, Caruso B, Perbellini O, Colarossi S, et al. How much specific is the association between hymenoptera venom allergy and mastocytosis? Allergy. 2009;64:1379–82.
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–32.
Koenig M, Morel J, Reynaud J, Varvat C, Cathébras P. An unusual cause of spontaneous bleeding in the intensive care unit – mastocytosis: a case report. Cases J. 2008;1:100.
Afrin LB. The presentation, diagnosis and treatment of mast cell activation syndrome. Curr Allergy Clin Immunol. 2014;27:146–60.